Clinical Trial Update: TRANSFORM Heart Failure with Reduced Ejection Fraction [NA]

View source ↗

Summary

The TRANSFORM trial for heart failure with reduced ejection fraction has been withdrawn, with no current status reported.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure with Reduced Ejection Fraction

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Heart Failure, Systolic | NA | Status: WITHDRAWN